
pmid: 22365254
For selected parenchymal lung disease patients who fail to respond to medical therapy and demonstrate declines in function that place them at increased risk for mortality, lung transplantation should be considered. Lung transplantation remains a complex medical intervention that requires a dedicated recipient and medical team. Despite the challenges, lung transplantation affords appropriate patients a reasonable chance at increased survival and improved quality of life. Lung transplantation remains an appropriate therapeutic option for selected patients with parenchymal lung disease.
Scleroderma, Systemic, Waiting Lists, Contraindications, Patient Selection, Idiopathic Pulmonary Fibrosis, Histiocytosis, Langerhans-Cell, Sarcoidosis, Pulmonary, Humans, Lymphangioleiomyomatosis, Lung Diseases, Interstitial, Referral and Consultation, Lung Transplantation
Scleroderma, Systemic, Waiting Lists, Contraindications, Patient Selection, Idiopathic Pulmonary Fibrosis, Histiocytosis, Langerhans-Cell, Sarcoidosis, Pulmonary, Humans, Lymphangioleiomyomatosis, Lung Diseases, Interstitial, Referral and Consultation, Lung Transplantation
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 10 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
